Emergence of multi-drug-resistant Acinetobacter anitratus species in neonatal and paediatric intensive care units in a developing country: concern about antimicrobial policies

References

• Celis R, Torres A, Gatell JM, el al. Nosocomial pneumonia: a multivariate analysis of risk and prognosis. Chest 1988; 93: 318–24.
   PubMed Web of Science ®Google Scholar
• Torres A, Aznar R, Gatell JM, et al. Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990; 142: 523–8.
   PubMed Web of Science ®Google Scholar
• Levin AS, Barone AA, Penco J, et al. Intravenous colistin as therapy for nosocomial infections caused by multi-drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999; 28: 1008–11.
   PubMed Web of Science ®Google Scholar
• Bergogne-Berezin E, Towner KJ. Acinetobacter spp as nosocomial pathogens: microbiological, clinical and epidemiological features. Clin Microbiol Rev 1996; 9: 148–65.
   PubMed Web of Science ®Google Scholar
• Mishra A, Mishra S, Jaganath G, Mittal RK, Patra DP. Acinetobacter sepsis in newborns. Indian Pediatr 1998; 35: 27–32.
   PubMedGoogle Scholar
• Sakata H, Fujita K, Maruyama S, Kakeshashi H, Mori Y, Yoshioko H. Acinetobacter calcoaceticus biovar anitratus septicaemia in a neonatal intensive care unit: epidemiology and control. J Hosp Infect 1989; 14: 15–22.
   PubMed Web of Science ®Google Scholar
• Nunez ML, Martinez-Toldos MC, Bru M, Simarro E, Segovia M, Ruiz J. Appearance of resistance to meropenem during the treatment of a patient with meningitis by Acinetobacter. Scand J Infect Dis 1998; 30: 421–3.
   PubMedGoogle Scholar
• Shi ZY, Liu PY, Lau Y, Lin Y, Hu BS, Shir J-M. Antimicrobial susceptibility of clinical isolates of Acinetobacter baumanni. Diagn Microbiol Infect Dis 1996; 24: 81–5.
   PubMed Web of Science ®Google Scholar
• Jimenez-Mejias ME, Pachon J, Becerril B, Palomino-Nicas J, Rodriguez-Cobacho A, Revuelta M. Treatment of multi-drug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam. Clin Infect Dis 1997; 24: 932–5.
   PubMed Web of Science ®Google Scholar
• Hogg GM, Barr JG, Webb CH. In-vitro activity of the combination of colistin and rifampicin against multi-drug-resistant strains of Acinetobacter baumannii. J Antimicrob Chemother 1998; 41: 494–5.
   PubMed Web of Science ®Google Scholar
• Tankovic J, Legrand P, De Gatines G, Chemineau V, Brun-Buisson C, Duval J. Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods. J Clin Microbiol 1994; 32: 2677–81.
   PubMed Web of Science ®Google Scholar
• Go ES, Urban C, Burns J, et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 1994; 344: 1329–32.
   PubMed Web of Science ®Google Scholar
• Torres A, el-Ebiary M, Rano A. Respiratory infectious complications in the intensive care unit. Clin Chest Med 1999; 20: 287–301.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standards M2-A5. Villanova, PA: 1993.
   Google Scholar
• Bernstein JM, Campbell GD. Treatment of pneumonia and its implications for antimicrobial resistance. Chest 1999; 115: 15–25.
   Web of Science ®Google Scholar
• Meyer KS. Nosocomial outbreak of Klebsiella infection resistant to late generation cephalosporins. Ann Intern Med 1993; 119: 353–8.
   PubMed Web of Science ®Google Scholar
• Ballow CH, Schentag JJ. Trends in antibiotic utilization and bacterial resistance: report of the National Nosocomial Resistance Surveillance Group. Diagn Microbiol Infect Dis 1992; 15: 375–425.
   PubMed Web of Science ®Google Scholar
• Follath F, Costa E, Thommen A, Frei R, Burdeska A, Meyer J. Clinical consequences of development of resistance to third generation cephalosporin. Eur J Clin Microbiol 1987; 6: 446–50.
   PubMedGoogle Scholar
• Wilkinson D, Moore DA. HIV-related tuberculosis in South Africa—clinical features and outcome. S Afr Med J 1996; 86: 64–7.
   PubMed Web of Science ®Google Scholar
• Pinner RW, Teutsch SM, Simonsen L, et al. Trends in infectious diseases mortality in the United States. JAMA 1996; 275: 189–93.
   PubMed Web of Science ®Google Scholar
• Yates RR. New intervention strategies for reducing antibiotic resistance. Chest 1999; 115: 245–75.
   Web of Science ®Google Scholar
• Pillay T, Pillay DG, Adhikari M, Sturm AW. Pipercillin/tazobactam in the treatment of Klebsiella pneumonia infections in neonates. Am J Perinatol 1998; 15: 47–51.
   PubMed Web of Science ®Google Scholar
• Rice LB, Eckstein EC, DeVente J, Shlaes DM. Ceftazidime-resistant Klebsiella pneumonia isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996; 23: 118–24.
   PubMed Web of Science ®Google Scholar
• Murray BE. Can antibiotic resistance be controlled? N Engl J Med 1994; 330: 1229–30.
   PubMed Web of Science ®Google Scholar
• Koeleman JG, Parlevleit GA, Dijkshoorn L, Savelkoul PH, Vandenbroucke-Grauls CM. Nosocomial outbreak of multi-resistant Acinetobacter baumannii on a surgical ward: epidemiology and risk factors for acquisition. J Hosp Infect 1997; 37: 113–23.
   PubMed Web of Science ®Google Scholar
• Cordero L, Ayers LW, Davis K. Neonatal airway colonisation with gram-negative bacilli: associated with severity of bronchopulmonary dysplasia. J Clin Microbiol 1997; 35: 1394–7.
   PubMed Web of Science ®Google Scholar
• Vincent JL. Prevention of nosocomial bacterial pneumonia. Thorax 1999; 54: 544–9.
   PubMed Web of Science ®Google Scholar
• Pillay DG, Pillay T. The clinical significance of Acinetobacter spp. S Afr J Epidemiol Infect 1998; 13: 98–100.
   Google Scholar
• Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 1998; 36: 1938–41.
   PubMed Web of Science ®Google Scholar
• Musa EK, Desai N, Casewell MW. The survival of Acinetobacter calcoaceticus inoculated on fingertip and formica. J Hosp Infect 1990; 15: 219–27.
   PubMed Web of Science ®Google Scholar
• Barriga GA, Rodriguez EN, Durazo FQ, Esparza SE, Lisker AM. Patterns of antibiotic susceptibility of nosocomial bacteriae strains to meropenem, a national multicentric study (abstr). Twentieth International Congress of Chemotherapy, Sydney, July 1997; p20a.
   Google Scholar
• Fagon J-Y, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1989; 139: 877–84.
   PubMed Web of Science ®Google Scholar
• Greco PJ, Eisenberg JM. Changing physicians' practices (letter). N Engl J Med 1993; 329: 1271–4.
   PubMed Web of Science ®Google Scholar
• Villers D, Espaze E, Coste-Burel M, et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med 1998; 129: 182–9.
   PubMed Web of Science ®Google Scholar